Close Menu

PHILADELPHIA (GenomeWeb) – At the American Association for Clinical Chemistry annual meeting here today, BioRad Laboratories announced that it has received 510(k)clearance from the US Food and Drug Administration for a multi-analyte quality control designed to monitor the performance of in vitro nucleic acid tests for viral load assays used in the diagnosis of human immunodeficiency type 1, hepatitis B, and hepatitis C viruses.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.